- Home
- DPG vs LAB Comparison
DPG vs LAB Comparison
Compare DPG & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPG
- LAB
- Stock Information
- Founded
- DPG 2011
- LAB 1999
- Country
- DPG United States
- LAB United States
- Employees
- DPG N/A
- LAB N/A
- Industry
- DPG Trusts Except Educational Religious and Charitable
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- DPG Finance
- LAB Industrials
- Exchange
- DPG Nasdaq
- LAB Nasdaq
- Market Cap
- DPG 477.4M
- LAB 449.9M
- IPO Year
- DPG N/A
- LAB 2011
- Fundamental
- Price
- DPG $13.16
- LAB $1.23
- Analyst Decision
- DPG
- LAB Hold
- Analyst Count
- DPG 0
- LAB 2
- Target Price
- DPG N/A
- LAB $1.35
- AVG Volume (30 Days)
- DPG 150.1K
- LAB 1.5M
- Earning Date
- DPG 01-01-0001
- LAB 11-04-2025
- Dividend Yield
- DPG 9.09%
- LAB N/A
- EPS Growth
- DPG N/A
- LAB N/A
- EPS
- DPG N/A
- LAB N/A
- Revenue
- DPG N/A
- LAB $169,737,000.00
- Revenue This Year
- DPG N/A
- LAB N/A
- Revenue Next Year
- DPG N/A
- LAB N/A
- P/E Ratio
- DPG N/A
- LAB N/A
- Revenue Growth
- DPG N/A
- LAB 79.77
- 52 Week Low
- DPG $7.90
- LAB $0.92
- 52 Week High
- DPG $13.58
- LAB $2.25
- Technical
- Relative Strength Index (RSI)
- DPG 54.24
- LAB 48.04
- Support Level
- DPG $13.01
- LAB $1.16
- Resistance Level
- DPG $13.25
- LAB $1.26
- Average True Range (ATR)
- DPG 0.15
- LAB 0.07
- MACD
- DPG 0.00
- LAB 0.01
- Stochastic Oscillator
- DPG 73.79
- LAB 72.50
About DPG Duff & Phelps Utility and Infrastructure Fund Inc.
Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund. Its investment objective is to seek total return, resulting from a high level of current income, with an emphasis on providing tax-advantaged dividend income.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.